Edgewise Therapeutics, Inc. (EWTX)

28.39 -0.49 (-1.70%) USD  |  NASDAQ  |  Mar 05, 16:00
28.35 -0.04 (-0.14%) After-Hours: 20:00
More

Edgewise Therapeutics Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for EWTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
Glaukos Corp. Upgrade
Nuvalent, Inc. --
Neurocrine Biosciences, Inc. Upgrade
Omeros Corp. --
Agios Pharmaceuticals, Inc. Upgrade